Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-09

Clinical Trial Update: Propolis Improves Glycemic Control in Subjects With Type 2 Diabetes and Chronic Periodontitis [Phase 4]

View source ↗

Summary

Phase 4 study investigating propolis for glycemic control in adults with Type 2 diabetes mellitus and chronic periodontitis. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propolis (propolis)

Snippet

Sponsor: Mohamed Anees | Conditions: Diabetes Mellitus, Periodontitis | Phase 4 | Status: COMPLETED